RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:While other biotech steam forward. DUG looks behind the Not that simple to buy more after almost seven Years of limbo and decline. GUD on a balance sheet approached it is a no brainer but betting on MNGT again ..and again is a nightmare. How many times can they get it wrong? How long can they sit on the cash and do nothing? If they do not resign will they add more fire power to MNGT? Or will they remain in hibernation forever? You cannot keep expecting MNGT to change when they keep doing the same thing and expect investors and the market to reward then with higher share price. Because of GUD I have done very well with PRN and I am deep with ATE. In the last six months I have beaten the market by far mostly US tech and biotech, amazon. The only dog GUD. 4% of the portfolio. In Late March with their cash there were huge opportunities for GUD but they were at sleep as usual. GUD has lost investor's faith. Even if the share price goes back to $10 the original investors will not keep up with market index. In the next five Years GUD would have to go to $15 or more to keep up with market index. Not only we lost capital by staying with GUD but we also lost opportunity cost of not investing in winners/profits. I guess if you are GT and entering into GUD now the down site is low but he too may wait Years a d piss ing in the wind like most of us long